Novel B-Cell Epitopes of Non-Neutralizing Antibodies in the Receptor-Binding Domain of the SARS-CoV-2 S-Protein with Different Effects on the Severity of COVID-19 › Research Explorer

DOI

https://doi.org/10.1134/S000629792309002X
Final published version

Andrey L Matveev
Oleg V Pyankov
Yana A Khlusevich
Olga V Tyazhelkova
Ljudmila A Emelyanova
Anna M Timofeeva
Andrey V Shipovalov
Anton V Chechushkov
Natalia S Zaitseva
Gleb A Kudrov
Gaukhar M Yusubalieva
Saule M Yussubaliyeva
Oxana A Zhukova
Artem Yu Tikunov
Vladimir P Baklaushev
Sergey E Sedykh
Galina I Lifshits
Nina V Tikunova

Original language	English
Pages (from-to)	1205-1214
Number of pages	10
Journal	Biochemistry (Moscow)
Volume	88
Issue number	9
DOIs	https://doi.org/10.1134/S000629792309002X
Publication status	Published - Sept 2023

Research areas

Animals, Mice, Humans, COVID-19, SARS-CoV-2/metabolism, Antibodies, Neutralizing/chemistry, Epitopes, B-Lymphocyte, Antibodies, Viral, coronavirus infection, antiviral properties, receptor-binding domain, SARS-CoV-2, RBD, antibodies

OECD FOS+WOS

1.06.CQ BIOCHEMISTRY & MOLECULAR BIOLOGY
1.06 BIOLOGICAL SCIENCES

ID: 56201722